Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.


OBJECTIVE AND DESIGN Elevated blood pressure and insulin resistance are strongly associated in patients. We explored the potential for the anti-hypertensive angiotensin II type 1-receptor (ATR(1)) antagonists to improve insulin sensitivity through modulation of the nuclear receptor PPARgamma, in vitro and in vivo compared to the potent insulin sensitizer… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.